 | | | | A pharmaceutical company in Pakistan plans to import the antiviral drug remdesivir, which has shown promise in treating coronavirus patients, from neighbouring Bangladesh, it said in a stock exchange filing on Friday. | | |
| | | China's Ministry of Agriculture and Rural Affairs said on Friday it had found a new outbreak of African swine fever near the city of Lanzhou in northwestern Gansu province. | | |
| | | Drugmaker Sun Pharmaceutical Industries Ltd said on Friday it has received Indian regulatory approval to start clinical trials of a pancreatitis drug in COVID-19 patients. | | |
| | | A raft of South African tobacco companies, activists and associations are seeking legal action over the ban on cigarette sales during the country's coronavirus lockdown. | | |
| | | U.S. hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug touted by President Donald Trump as a COVID-19 treatment, after several studies suggested it is not effective and may pose significant risks. | | |
| | | Sanofi's head of vaccines David Loew will quit to become chief executive of Ipsen from July 1, the two French drugmakers said on Friday. | | |
| | | Malaysia reported 103 cases of new coronavirus infections on Friday, mostly involving foreigners, the health ministry said, raising the country's cumulative total to 7,732 cases. | | |
| | | Indonesia reported on Friday 678 new coronavirus infections, taking the total number of cases in the Southeast Asian country to 25,216, said health ministry official Achmad Yurianto. | | |
| | | South Korean health authorities said on Friday they would request imports of Gilead Sciences Inc's anti-viral drug remdesivir to treat COVID-19, as new outbreaks of the disease flare as social distancing restrictions are eased. | | |
| | | Russia on Friday reported 232 deaths from the new coronavirus in the last 24 hours, a record one-day amount that pushed the nationwide death toll to 4,374. | | |
| | | As India's health system grapples with the coronavirus, doctors are increasingly going online to consult with patients suffering less critical or chronic diseases, while the south Asian economy prepares to emerge from a nationwide lockdown. | | |
|
| |
